Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $760.94 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Philips Electronics North America Corporation | $167.57 | 3 | $0 (2018) |
| 3B Medical, Inc. | $165.63 | 1 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $140.89 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $97.13 | 1 | $0 (2017) |
| Jazz Pharmaceuticals Inc. | $80.86 | 2 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $32.80 | 2 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $25.52 | 2 | $0 (2017) |
| Biohaven Pharmaceutical Holding Company Ltd. | $17.82 | 1 | $0 (2022) |
| Lilly USA, LLC | $16.39 | 1 | $0 (2018) |
| PFIZER INC. | $16.33 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $213.87 | 3 | 3B Medical, Inc. ($165.63) |
| 2023 | $58.41 | 2 | Harmony Biosciences LLC ($58.41) |
| 2022 | $52.06 | 2 | Harmony Biosciences LLC ($34.24) |
| 2019 | $16.33 | 1 | PFIZER INC. ($16.33) |
| 2018 | $183.96 | 4 | Philips Electronics North America Corporation ($167.57) |
| 2017 | $236.31 | 7 | Boehringer Ingelheim Pharmaceuticals, Inc. ($97.13) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/24/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $30.62 | General |
| Category: Narcoplepsy | ||||||
| 06/01/2024 | 3B Medical, Inc. | LUNA (Device) | Food and Beverage | Cash or cash equivalent | $165.63 | General |
| Category: VENTILATOR, NON-CONTINUOUS (RESPIRATOR) | ||||||
| 03/27/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $17.62 | General |
| Category: Narcoplepsy | ||||||
| 11/08/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $33.73 | General |
| Category: SLEEP MEDICINE | ||||||
| 04/07/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $24.68 | General |
| Category: SLEEP MEDICINE | ||||||
| 11/04/2022 | Harmony Biosciences LLC | Wakix (Drug) | Food and Beverage | Cash or cash equivalent | $34.24 | General |
| Category: Neurological Disorders | ||||||
| 03/24/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: PRIMARY CARE | ||||||
| 08/23/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/12/2018 | Lilly USA, LLC | JARDIANCE (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Diabetes | ||||||
| 10/29/2018 | Philips Electronics North America Corporation | DreamWear Full (Device) | Food and Beverage | Cash or cash equivalent | $66.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/13/2018 | Philips Electronics North America Corporation | DreamWear Full (Device) | Food and Beverage | Cash or cash equivalent | $37.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/05/2018 | Philips Electronics North America Corporation | DreamWear Full (Device) | Food and Beverage | Cash or cash equivalent | $63.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/10/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/16/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.75 | General |
| Category: Cardiovascular | ||||||
| 06/05/2017 | Jazz Pharmaceuticals Inc. | Xyrem (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Neurology | ||||||
| 05/25/2017 | Jazz Pharmaceuticals Inc. | Xyrem (Drug) | Food and Beverage | In-kind items and services | $67.10 | General |
| Category: Neurology | ||||||
| 03/01/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.77 | General |
| Category: Cardiovascular | ||||||
| 02/16/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $97.13 | General |
| Category: DIABETES | ||||||
| 02/15/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 830 | 1,100 | $1.1M | $175,046 |
| 2022 | 15 | 639 | 883 | $602,902 | $112,289 |
| 2021 | 13 | 604 | 1,104 | $1.0M | $164,815 |
| 2020 | 9 | 511 | 717 | $787,082 | $132,745 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 165 | 165 | $635,250 | $89,667 | 14.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 66 | 66 | $267,300 | $38,216 | 14.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 155 | 246 | $50,676 | $18,613 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 114 | $34,656 | $12,389 | 35.7% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 82 | 164 | $84,977 | $7,005 | 8.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $10,370 | $2,981 | 28.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 17 | 22 | $8,228 | $1,167 | 14.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 29 | $4,495 | $1,098 | 24.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 37 | 67 | $6,801 | $829.91 | 12.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 71 | 88 | $792.00 | $739.20 | 93.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 13 | 13 | $2,756 | $631.24 | 22.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 16 | $596.48 | $584.48 | 98.0% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 16 | 16 | $1,925 | $348.97 | 18.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 21 | 30 | $1,200 | $285.60 | 23.8% |
| 94762 | Test to measure oxygen level in blood using ear or finger device continuously overnight | Office | 2023 | 13 | 13 | $1,560 | $264.96 | 17.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 17 | $1,428 | $225.76 | 15.8% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 75 | 75 | $288,750 | $42,774 | 14.8% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 41 | 41 | $166,050 | $24,493 | 14.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 141 | 251 | $51,706 | $20,270 | 39.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 124 | $37,696 | $14,004 | 37.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 44 | 49 | $7,595 | $2,227 | 29.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 20 | 20 | $6,100 | $1,837 | 30.1% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2022 | 19 | 38 | $19,690 | $1,727 | 8.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 16 | 25 | $9,350 | $1,564 | 16.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 29 | 64 | $6,496 | $868.19 | 13.4% |
About Dr. Paul Raymond, MD
Dr. Paul Raymond, MD is a Sleep Medicine healthcare provider based in Homer, Alaska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912075920.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Raymond, MD has received a total of $760.94 in payments from pharmaceutical and medical device companies, with $213.87 received in 2024. These payments were reported across 19 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($760.94).
As a Medicare-enrolled provider, Raymond has provided services to 2,584 Medicare beneficiaries, totaling 3,804 services with total Medicare billing of $584,895. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Sleep Medicine
- Other Specialties Family Medicine
- Location Homer, AK
- Active Since 11/30/2006
- Last Updated 01/29/2024
- Taxonomy Code 207QS1201X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912075920
Products in Payments
- DreamWear Full (Device) $167.57
- LUNA (Device) $165.63
- JARDIANCE (Drug) $113.52
- WAKIX (Drug) $106.65
- Xyrem (Drug) $80.86
- Wakix (Drug) $34.24
- ELIQUIS (Drug) $25.52
- NURTEC ODT (Drug) $17.82
- FARXIGA (Drug) $17.65
- CHANTIX (Drug) $16.33
- SYMBICORT (Drug) $15.15
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.